| CPC A61F 13/00063 (2013.01) [A61F 13/0236 (2013.01); A61H 7/007 (2013.01); A61K 9/7084 (2013.01); A61K 31/05 (2013.01); A61K 31/352 (2013.01); A61H 9/005 (2013.01); A61H 23/02 (2013.01); A61H 2201/0153 (2013.01); A61H 2201/105 (2013.01); A61H 2201/1253 (2013.01); A61N 1/0456 (2013.01)] | 18 Claims |
|
1. An apparatus configured to treat myofascial tissue imbalances comprising:
a soft tissue mobilizing device having a front surface and an opposite back surface;
at least one transdermal receiving pad having medication disposed thereon that is adapted to be absorbed through a user's skin, wherein the at least one transdermal pad is coupled to the opposite back surface of the soft tissue mobilizing device, wherein the medication is at least one cannabinoid or at least one terpene, and wherein the cannabinoid or the terpene is comprised of an oil, a gel or a lotion;
wherein the front or back surface of the soft tissue mobilizing device is coupled to one or more transdermal stimulators arranged in cooperation thereof to stimulate transdermal features of the at least one transdermal receiving pad, thereby increasing a penetration and delivery rate of the medication, wherein the stimulator is a vibrator, a pressure applicator, or a transcutaneous electrical nerve stimulation device; and
the front surface having a detachable grasping mechanism disposed thereon that allows a therapist or the user to grasp the grasping mechanism to manually lift and shift the device by hand via a flossing motion while the mobilizing device is adhered to a soft tissue area of the user being treated;
whereby the manual lifting and shifting of the user's soft tissue increases blood circulation around muscle and myofascial tissue of the user that helps to reduce a time period for normalizing the myofascial tissue area being treated, reduce a time period of alleviating muscle tension, aches, and pain of the user, and increase an absorption period of the medication through the user's skin.
|